Cisapride Tablets and Insulin glargine and lixisenatide
Determining the interaction of Cisapride Tablets and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisapride
Brand name: Propulsid
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Tablets-Insulin glargine and lixisenatide Subcutaneous
- Cisapride Tablets-Insulin glargine, recombinant Subcutaneous
- Cisapride Tablets-Insulin glulisine
- Cisapride Tablets-Insulin Glulisine (Cartridges and Pens)
- Cisapride Tablets-Insulin Glulisine (Vials)
- Cisapride Tablets-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Cisatracurium
- Insulin glargine and lixisenatide-Cisatracurium Besylate
- Insulin glargine and lixisenatide-Cisatracurium Besylate Injection
- Insulin glargine and lixisenatide-Cisatracurium besylate Intravenous
- Insulin glargine and lixisenatide-Cisplatin
- Insulin glargine and lixisenatide-Cisplatin Intravenous